Fevris Derzelas
ᴍᴇᴅɪᴄᴀʟ ᴏꜰꜰɪᴄᴇʀ
Out of Character Information
- Intent: Create an anaesthetic produced by Noxis Corporation and the first drug in the Nox series.
- Image Source: Header designed by Freepik; David Woodman; morphine formula from wikipedia.
- Canon Link: N/a.
- Permissions: N/a.
- Primary Source: N/a.
Production Information
- Manufacturer: NoxaCorp.
- Affiliation:
- Closed-Market.
- The First Order.
- Model: N/a.
- Modularity: None.
- Production: Mass-Produced.
- Material:
- Pharmaceutical Components.
Technical Information
- Classification: Anaesthetic.
- Method of Consumption:
- Topical: Drug can be applied to a body surface (e.g. skin); gel.
- Parenteral: Administered by intramuscular or intravenous injection.
- Average Life:
- Topical: Six standard hours before needing reapplication.
- Parenteral: Ten standard hours before needing reapplication.
- Purpose: Numbing pain perception.
- Side Effects: Normally none. Potentially:
- Shivering and feeling cold.
- Decreased reflex speed.
- Nausea and vomiting.
- Breathing difficulty.
- Contraindications:
- Pregnancy.
- Individuals who have not yet reached biological maturity.
- Individuals with respiratory conditions.
- Nutritional Value: None.
Special Features
- Potent anesthetic with no effect on cognition and consciousness.
- Bright blue color.
- Swift effect on the target area or body.
Strengths
- No Pain: The Nox-1 agent was designed to achieve the effects of a potent anesthetic without affecting consciousness or over-relaxing the muscles by only affecting the body's nocireceptors. This means that a subject under the influence of Inzamine will not feel pain, but will still be able to move normally and be in control of their motions. This is incredibly useful in situations were pain can cause shock or hinder the individual.
- Benefits out-weight drawbacks: If used responsibly, Inzamine has very little side effects on the individual if any at all. It acts quickly once injected or placed and blocks the individual's ability feel pain.
- Local Or General: Coming both in a gel version for localized wounds or superficial injuries and in an injectable format (auto-injectable device), the Nox-1 agent can be used to relieve pain quickly either in a specific part of the body or systematically.
- Resilient Soldiers: When used in its injectable format, Inzamine blocks pain perception in the whole body, potentially allowing the user to shrug off hits and wounds that would otherwise incapacitate them and thus be able to make a longer last stand or get to where they need to get to receive further medical assistance.
Weaknesses
- Cannot Learn Without Pain: Pain exists for a reason. It is a body's way of expressing that something is wrong and to try to keep the individual from movement or actions that might make the situation worse. The Nox-1 agent blocks pain, but it is not a healing agent. While under its effects, the user may underestimate the gravity of their injuries or never be aware that they exist on the first place if they are internal. This puts them at dire risk of succumbing to wounds left untreated or never noticed.
- Relief, not Aid: The fact that Inzamine would make the pain of a broken leg disappear doesn't mean that its a good idea to walk on it and even if pain is not felt allowing an individual to retain their vigor and resolve, the body will give in to its wounds if these are extensive.
- After effect: Once the Nox-1 agent starts to be filtered out of the body, a period of over-sensitivity as the individual gets used to feeling pain once more will ensue provoking hyperalgesia. This lasts for a few hours.
- Addiction: Like most high-potency pain-killers, it is possible to develop an addiction if overused. On top of this, abusive use of the substance increases the incidence of side effects and has detrimental effects on the overall health of the individual that may lead to serious complications or death. Abstinence is characterized by intense hyperalgesia and narcolepsy, making recovery difficult.
- Overdose: It is possible to overdose. Overdose causes the body to go into shock and can lead to death through respiratory arrest.
A field medic, Fevris Derzelas often found herself in the presence of individuals that were incapacitated and lost their lives to the weakness and distraction that pain represented, or spent their last moments vulnerable and in agony. A solution to this jarring reality came in the form a modified, synthetically produced anesthetic and the first of many drugs and stims produced by NoxaCorp: the Nox-1 Agent, Inzamine.
Spreading rapidly though the body (if injected) or the area (if applied as gel), the Nox-1 Agent finds and deactivates the nocireceptors of an organism, the nerve endings meant to perceive pain. However, it has no further effect on the nerve system than this and does not interact with the muscles, thus becoming a form of general anesthesia that does not produce unconsciousness or inability to move. However, this also means the drug is not suited for use during extensive surgery but rather as immediate pain relief of grave wounds or in extreme scenarios where getting to a medcenter is not an option.
Nox-1 agent injections are a common feature in the more advanced medkits and backpacks produced by NoxaCorp
